Substituted quinoline compounds and methods of use
US9598400B2 · kind B2 · utility
0Cited by
10References
18Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Aug 12, 2015 |
| Grant date | Mar 21, 2017 |
| Priority date | — |
| Expiry date | Aug 12, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel substituted quinoline compounds, pharmaceutical acceptable salts and formulations thereof useful in modulating the protein tyrosine kinase activity, and in modulating cellular activities such as proliferation, differentiation, apoptosis, migration and invasion. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.